imiquimod (E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the imiquimod drug offered from E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.. This Increased Cytokine Activity [PE],Increased Cytokine Production [PE],Interferon Inducers [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.
NON-PROPRIETARY NAME: imiquimod
SUBSTANCE NAME: IMIQUIMOD
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Increased Cytokine Activity [PE],Increased Cytokine Production [PE],Interferon Inducers [MoA]
ROUTE: TOPICAL
DOSAGE FORM: CREAM
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2010-02-25
END MARKETING DATE: 0000-00-00


imiquimod HUMAN PRESCRIPTION DRUG Details:

Item Descriptionimiquimod from E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.
LABELER NAME: E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/g)
START MARKETING DATE: 2010-02-25
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0168-0432_fdbbf340-e87c-44ed-9274-148846ffd788
PRODUCT NDC: 0168-0432
APPLICATION NUMBER: ANDA078548

Other IMIQUIMOD Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Apotex Corp.Imiquimod
E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.imiquimod
Glenmark Pharmaceuticals Inc., USAImiquimod
Perrigo New York IncImiquimod
Physicians Total Care, Inc.Imiquimod
Strides Shasun Limitedimiquimod
Taro Pharmaceutical Industries Ltd.Imiquimod
Taro Pharmaceuticals U.S.A., Inc.Imiquimod
Valeant Pharmaceuticals North America LLCAldara